As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...

A study links reduced mitochondrial quantity to the development of obesity. By studying Finnish twins, researchers identified ...

Researchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less ...

Children attending NHS excess weight clinics are overwhelmingly from deprived backgrounds, and often face complex health and ...

Ultra-processed foods are associated with higher incidences of chronic diseases * Consumption of ultra-processed foods is ...